Table 1.
Clinical characteristics of patients with percutaneous pulmonary valve implantation after Ross procedure
| Case | Sex | Age (y) | Time since Ross (y) | RV outflow tract | RV-PA conduit lesion |
|---|---|---|---|---|---|
| 1 | M | 42 | Unknown | Homograft (2nd) 21 mm | Predominant stenosis |
| 2 | M | 22 | 4 | Homograft (2nd) 20 mm | Predominant stenosis |
| 3 | F | 12 | 5 | Homograft 18 mm | Mixed dysfunction |
| 4 | M | 20 | 8 | Homograft (reconstructed) | Mixed dysfunction |
| 5 | M | 38 | 2.5 | Homograft 23 mm | Predominant stenosis |
| 6 | F | 26 | 5 | Homograft 24 mm | Predominant stenosis |
| 7 | M | 11 | 7 | Homograft 19 mm | Predominant stenosis |
| 8 | M | 13 | 10 | Homograft 16 mm | Predominant regurgitation |
| 9 | M | 71 | 34 | Porcine valve conduit (unknown) | Predominant stenosis |
| 10 | F | 24 | 8 | Homograft (unknown) | Predominant regurgitation |
| 11 | F | 15 | 8 | Homograft 20 mm | Predominant regurgitation |
| 12 | M | 48 | 31 | Homograft (unknown) | Predominant regurgitation |
RV, Right ventricle; PA, pulmonary artery.